Method for evaluating obesity controller
A control agent and obesity technology, applied in chemical instruments and methods, compound screening, animal/human protein, etc., can solve problems such as unclear changes in insulin secretion
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0062] Example 1: Postprandial Insulin Secretion Increased by Ingestion of Carbohydrates and Lipids
[0063] Fasting mice (C57BL / 6J, male, 7-8 weeks old) were divided into groups, ten in each group, and the mice were orally given only 2 mg / g of body weight glucose ( Wako Pure Chemical Industries, Ltd.) as carbohydrates, or triolein (Sigma Corp.) of 0.5, 1.0 or 2.0 mg / g body weight was also administered together with carbohydrates as lipids, and the emulsion was made with egg yolk lecithin Obtained by emulsifying 0.02 mg / g body weight of lipids (carbohydrate+lipid 0, carbohydrate+lipid 1, carbohydrate+lipid 2, and carbohydrate+lipid 3, respectively). The composition of the administered substances is shown in Table 1. Before the administration and 10 minutes and 30 minutes after the administration, blood samples were taken from the orbital vein of each mouse, the blood insulin level was measured, and the area under the curve (AUC) of the graph was calculated. Measurement of in...
Embodiment 2
[0071] Example 2: Correlation between postprandial insulin secretion and obesity
[0072] (1) Determination of postprandial insulin secretion
[0073] Glyceryl triolein (Sigma Corp.) was used as the lipid and starches (gelatinized, obtained from sweet potato, cassava, potato, kudzu, sago, waxy corn, from Nippon Starch Chemical Co., Ltd.) as the carbohydrate.
[0074] Fasting mice (C57BL / 6J, male, 10 to 11 weeks old) were divided into groups of 4 to 5, and the mice were orally administered carbohydrates at 2 mg / g body weight using a probe, or together with carbohydrates Triolein plus 0.08 mg / g body weight was also administered at 2 mg / g body weight. After 10 minutes of administration, blood was collected from the orbital vein of each mouse, and blood glucose level and blood insulin level were measured. Blood glucose levels were measured using a small blood glucose meter (glucose dehydrogenase / potential difference measurement, Roche Diagnostics, Inc.). Insulin levels were me...
Embodiment 3
[0086] Example 3: Inducibility of hypoinsulin secretion by glycogen
[0087] Triolein (Sigma Corp.) was used as lipid, while glucose (WakoPure Chemical Industries, Ltd.) or glycogen (from sweet corn, QP Corp.) was used as carbohydrate.
[0088] Fasting mice (C57BL / 6J, male, 10 to 11 weeks old) were divided into groups, 9 to 10 in each group, and 2 mg / g body weight of glucose was orally administered to the mice using a probe; Together with 2 mg / g body weight of triolein obtained by emulsifying 0.02 mg / g body weight of lipid with egg yolk lecithin (glucose, and glucose+lipid, respectively); 2 mg / g body weight glycogen; or triolein (TAG) at 2 mg / g body weight was also given together with glycogen in the form of an emulsion obtained by emulsifying 0.02 mg / g body weight lipid with egg yolk lecithin (respectively for glycogen, and glycogen + lipid). The compositions of the administered substances are shown in Table 4. Before the administration, and 10 minutes and 30 minutes after...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com